These results highlighted that the CTT-induced activation of CD4+ and CD8+ T cells at the early stage is critical for establishing persistent antitumor immunity, as this activation effectively suppressed lung metastasis and promoted long-term survival in B16F10 tumor-bearing mice. The gene discussed is CD8A; the disease is neoplasm.